ABOUT US

Engineered to Deliver What Pharma Hasn’t

VivaMed BioPharma is a clinical-stage pharmaceutical company advancing both new chemical entities and repurposed drugs in areas of urgent, unmet need—including pain, addiction, neurodegeneration, and rare diseases. We combine AI-powered development with global academic partnerships to accelerate progress, reduce risk, and bring forward therapies traditional pharma has overlooked.

WHAT SETS US APART

We’re Structured for Speed, Built for Impact

VivaMed isn’t built like traditional pharma—and that’s intentional. We’ve designed a model that identifies overlooked assets, accelerates development through AI, and leverages global partnerships to bring therapies to market faster and smarter. It’s how we reduce risk, increase success rates, and deliver meaningful change where it’s needed most.

  • AI-powered R&D from discovery to regulatory drafting
  • Expertise in both new chemical entities and repurposed drugs
  • 50+ active assets across high-need therapeutic areas
  • 150+ assets licensed or developed to date
  • 39 regulatory approvals supported globally
  • Strategic collaborations with 30+ academic institutions
  • Presence in five countries across three continents
  • Platform model designed for faster execution and lower attrition
Partner Today

PURPOSE STATEMENT

VivaMed BioPharma strategically selects and develops compounds that address critical unmet needs in medicine. For us, return on investment isn’t the end goal—it’s a byproduct of creating meaningful impact for patients, communities, and the future of global health.

LEADERSHIP TEAM

Built by Experts.
Driven by Execution.

From biotech founders to AI architects, regulatory strategists to clinical innovators—our team brings together the experience and executional power needed to change how drug development gets done.

Kendric

Healthcare entrepreneur with over 20 years in M&A, executive management, and drug development. Leads VivaMed in licensing and developing university-discovered drug assets, collaborating with over 30 university partners across 13 countries, and achieving regulatory approval for 39 drugs.

Kendric Speagle

Founder & Chief Executive Officer

Linkedin
John

Physician and entrepreneur with over 30 years of experience, having founded and scaled more than 15 companies. Notably founded NextCare Urgent Care and MeMD, a telehealth platform acquired by Walmart in 2021. Also founded Tribal Health, addressing healthcare disparities in Indigenous communities.

John Shufeldt, MD, JD, MBA, FACEP

President & Chief Medical Officer

Linkedin
Kate

Leader in healthcare philanthropy and business development, with a track record of securing over $100M for healthcare innovation. Formerly led major funding campaigns at Valleywise Health Foundation. At VivaMed, she drives biopharma commercialization, strategic investments, and industry partnerships.

Kate Fassett

Chief Development Officer

Linkedin
Glenn

Seasoned financial executive with expertise in financial services, technology, and healthcare. Played pivotal roles in expanding MicroAge to $5B in revenue and in the growth of NextCare and MeMD. As CFO of VivaMed, he drives the company's mission of transforming healthcare innovation.

Glenn Dean, MBA, CPA

Chief Financial Advisor

Linkedin
Dave

Seasoned technology and cybersecurity executive leading global digital and cloud transformation. As CIO and CISO, he integrates innovation, security, and governance to enable scalable, resilient, and secure cloud-first operations.

Dave Pulver

Chief Information Security Officer

Linkedin
Nicholas

Entrepreneur and published researcher specializing in generative AI. Author of "Elevate Your Health with AI," he builds AI-based agents to identify promising drug candidates, streamlining discovery workflows and accelerating progress on potential therapies.

Nicholas Harris

Chief Technology Officer

Linkedin
Manel

Expert in pharmaceutical innovation with experience in R&D, regulatory affairs, and product development. Leads initiatives to accelerate breakthrough therapies and expand VivaMed's impact.

Manel Ben-Aissa, PhD, MS

Chief Scientific Officer

Linkedin
Ben

Experienced life sciences attorney advising on IP, regulatory strategy, and biotech transactions. Kendric supports the company’s growth through legal oversight of partnerships, licensing, and compliance.

Ben Tietgen, JD

General Counsel

Linkedin

Presence Around the World

Headquarters & Offices Worldwide

CONTACT

Let's Connect

Have a question, opportunity, or idea? Whether you’re a researcher, investor, or potential partner—we’d love to hear from you.